RESEARCH

The CLQ lab's science is at the interface between chemistry and medicine and her lab houses biotechnology and data science to allow the detection of thousands of small molecules / lipids.

These molecules are measured with mass spectrometry instruments and then, data analytics, including machine learning, is performed to both discover biology and predict health & disease outcomes. In order to translate results into the clinic we also work with clinical trials and evidence portfolios.

CLICK the illustrations below to read about our work highlighted in press releases

CLICK THE GOOGLE SCHOLAR ICON

TO ACCESS

ALL PUBLICATIONS

Lipids are depleted in Alcoholic related Liver Disease. (2023)

CLQ was awarded 4.940.250 DKK by The Lundbeck Foundation to investigate lipids and Alzheimer’s & Diabetes (2021-2025)

Lipidomics of human tissue reveals diversity between body areas. (2020)

Higher brain glucose may mean more severe Alzheimer's. (2017)

Big Data discovers potential causal links in early Alzheimer's Disease. (2023)

Molecules in fecal samples for detecting liver disease (2022)

Could sleep molecules lead to blood test for Alzheimer's Disease?. (2019)

Brain Fatty acids dysregulated in Alzheimer's Disease. (2017)

DONORS & SPONSORS

We are very grateful for the samples that volunteers and donors give us and make our research possible.

As well, we thank all our collaborators and the funding bodies and sponsors that fund our research.

CURRENT FUNDERS:

.

PREVIOUS FUNDERS OVER THE YEARS:

.